Glutamate and GABA Receptors and Transporters —— Structure, Function and Pharmacology

----- 谷氨酸和γ-氨基丁酸受体和转运体

ISBN: 9780748408818 出版年：2001 页码：442 CRC Press

1. Ionotropic Glutamate Receptors: Functional and Pharmacological Properties in Relation to Constituent Subunits, Stuart G. Cull-Candy 2. Molecular Structure of Ionotropic Glutamate Receptors, Jan Egebjerg and Henrik S Jensen 3. Glutamate Receptor Trafficking, Guido Meyer and Jeremy M. Henley 4. Pharmacology of NMDA Receptors, David E. Jane 5. Pharmacology of AMPA/kainate Receptors, Ulf Madsen, Tommy N. Johansen, Tine B. Stensbol and Povl Krogsgaard-Larsen 6. Metabotropic Glutamate Receptors (mGluRs): Structure and Functions, J-P. Pin, L. Fagni and J. Bockaert 7. Pharmacology of Metabotropic Receptors, Darryle D. Schoepp and James A. Monn 8. Insights into GABAA Receptor Complexity From the Study of Cerebellar Granule Cells: Synaptic and Extrasynaptic Receptors, William Wisden and Mark Farrant 9. GABAA Receptor Complex: Structure and Function, Richard W. Olsen and Robert L. Macdonald 10. GABAA Receptor Complex: Structural Requirements for Ligand Interactions, P. Krogsgaard-Larsen, B. Ebert, U. Kristiansen, B. Madsen 11. Molecular Structure of the GABAB Receptors, N. Klix and B. Bettler 12. Phamacology of GABAB Receptors, N. G. Bowery 13. Structure, Function and Regulation of Glutamate Transporters, Line M. Levy 14. GABA Transporters: Functional and Pharmacological Properties, Arne Schousboe and Baruch Kanner 15. Transgenic Models for Glutamate Receptor Function, A.J. Doherty and G.L. Collingridge 16. Transgenic Models for GABAA Receptor Function, H. Mohler 17. Glutamatergic transmission: Therapeutic Prospects for Schizophrenia and Alzheimer's Disease, Nuri B. Farber, John W. Newcomer and John W. Olney 18. GABA-ergic Transmission: Therapeutic Prospects, Christian Thomsen and Bjarke Ebert MRC Centre, UK, R. Dingledine, Emory University of Medicine, USA, D.E. Jane, Univeristy of Bristol, UK, U. Madsen, Danish School of Pharmacy, S. Nakanishi, Kyoto University Faculty of Medicine, Japan, P.L. Ornstien and D.D. Schoepp, Lilly Corporate Centre, USA, M. Neilsen, St Hans Hospital, Denmark, R.L. Macdonald, University of Michegan Medical Centre, USA and R. Olsen, University of California, USA, P. Krogsgaard-Larsen, Danish School of Pharmacy, B. Bettler, Novartis Pharma Inc., Switzerland, W. Froestl, Novartis Pharma Inc., Switzerland, G. Gegelashvili, Danish School of Pharmacy, N.C. Damnbolt, University of Oslo, Norway, A. Shousboe, Danish School of Pharmacy, B.I. Kanner, The Hebrew University, Israel, G.L. Collingridge, Bristol University, UK, E. Mohler, Institute of Pharmacology, Switzerland, J. Drejer, NeuroSearch, Denmark, A.G. Chapman, Institute of Psychiatry, UK.